NEUROD1 and type 2 diabetes mellitus: In pancreatic islets, miR-802 can target neurogenic differentiation 1 (NeuroD1) and frizzled class receptor 5 (Fdz5), impairing insulin transcription and insulin secretion, respectively, and performing an important role in the development of T2D [90].